Neogen (NEOG) Depreciation & Amortization (CF) (2010 - 2025)
Neogen's (NEOG) quarterly Depreciation & Amortization (CF) came in at $3.3 million in Q4 2025, down 88.86% year-on-year from $30.0 million in Q4 2024, and down 88.48% quarter-over-quarter from $29.1 million in Q3 2025.
Neogen (NEOG) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
Neogen's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $3.3 million for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) fell 88.86% year-over-year to $3.3 million in Q4 2025; TTM through Feb 2026 was $62.7 million, a 46.93% decrease from a year earlier, with the FY2025 full-year figure at $119.5 million, up 2.37% from the prior year.
- Depreciation & Amortization (CF) retreated to $3.3 million in Q4 2025 per NEOG's latest filing, from $29.1 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $30.3 million in Q2 2025 and bottomed at $3.3 million in Q4 2025.
- The 5-year median for Depreciation & Amortization (CF) is $28.0 million (2023), against an average of $19.6 million.
- Across the five-year window, Depreciation & Amortization (CF) surged 401.55% in 2023 and plunged 88.86% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $5.8 million in 2021, then jumped by 358.71% to $26.7 million in 2022, then gained by 10.21% to $29.5 million in 2023, then rose by 1.96% to $30.0 million in 2024, then plunged by 88.86% to $3.3 million in 2025.
- Per Business Quant, the three latest NEOG Depreciation & Amortization (CF) figures stand at $3.3 million (Q4 2025), $29.1 million (Q3 2025), and $30.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 3.35 Mn |
| Nov 30, 2025 | 3.35 Mn |
| Aug 31, 2025 | 29.06 Mn |
| Aug 31, 2025 | 29.06 Mn |
| May 31, 2025 | 30.28 Mn |
| May 31, 2025 | 30.28 Mn |
| Feb 28, 2025 | 29.40 Mn |
| Feb 28, 2025 | 29.40 Mn |
| Nov 30, 2024 | 30.05 Mn |
| Nov 30, 2024 | 30.05 Mn |
| Aug 31, 2024 | 29.80 Mn |
| Aug 31, 2024 | 29.80 Mn |
| May 31, 2024 | 28.86 Mn |
| May 31, 2024 | 28.86 Mn |
| Feb 29, 2024 | 29.65 Mn |
| Feb 29, 2024 | 29.65 Mn |
| Nov 30, 2023 | 29.47 Mn |
| Nov 30, 2023 | 29.47 Mn |
| Aug 31, 2023 | 28.73 Mn |
| Aug 31, 2023 | 28.73 Mn |